Prudential Financial
GOSS icon

Prudential Financial’s Gossamer Bio GOSS Stock Holding History

Prudential Financial’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.5K Buy
227,550
+171,625
+307% +$47.9K ﹤0.01% 2451
2026
Q1 		$18.4K Buy
55,925
+18,310
+49% +$28.8K ﹤0.01% 2379
2025
Q4 		$117K Sell
37,615
-13,100
-26% -$37.4K ﹤0.01% 2112
2025
Q3 		$133K Buy
50,715
+300
+0.6% +$661 ﹤0.01% 2257
2025
Q2 		$62K Buy
50,415
+3,365
+7% +$3.67K ﹤0.01% 2325
2025
Q1 		$51.8K Hold
47,050
– – ﹤0.01% 2197
2024
Q4 		$42.6K Hold
47,050
– – ﹤0.01% 2225
2024
Q3 		$46.4K Buy
+47,050
New +$45.3K ﹤0.01% 2654
2021
Q1 		– Sell
-151,476
Closed -$1.46M – 2509
2020
Q4 		$1.46M Buy
151,476
+66,746
+79% +$657K ﹤0.01% 1565
2020
Q3 		$1.05M Buy
84,730
+220
+0.3% +$2.92K ﹤0.01% 1619
2020
Q2 		$1.1M Buy
84,510
+41,143
+95% +$517K ﹤0.01% 1602
2020
Q1 		$440K Buy
43,367
+353
+0.8% +$4.61K ﹤0.01% 1945
2019
Q4 		$673K Buy
+43,014
New +$866K ﹤0.01% 1984

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Prudential Financial's GOSS Position: Q2 2026 in Review

Prudential Financial increased its Gossamer Bio (GOSS) stake by 307% in Q2 2026, buying an estimated $47.9K and bringing the position to 227,550 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2451.

Prudential Financial first reported a position in GOSS in Q4 2019 and has held it in 13 quarters since. The position peaked at $1.46M in Q4 2020. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Prudential Financial held 227,550 shares of Gossamer Bio worth $37.5K as of Q2 2026.
  • Prudential Financial bought 171,625 Gossamer Bio shares in Q2 2026, an estimated $47.9K.
  • Gossamer Bio made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2451 holding.
  • Prudential Financial first reported a position in Gossamer Bio in Q4 2019 and has held it in 13 quarters since.
  • Prudential Financial's Gossamer Bio position peaked at $1.46M in Q4 2020.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.